Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Because peptides target specific pathways, they are often used in mens health to address concerns such as slower recovery, reduced muscle mass, stubborn body fat, low energy, declining libido, and healthy aging
Genetic subtyping of obesity reveals biological insights into the uncoupling of adiposity from its cardiometabolic comorbidities
The New England Journal of Medicine Dinsmore, T
Claytons research contributions to PT-141 development include: Principal investigator for pivotal Phase 2 dose-finding trial establishing optimal 1.75 mg dose Lead investigator for RECONNECT Phase 3 trials supporting FDA approval Development of responder analysis methodology for patient-reported outcomes in sexual dysfunction Neurobehavioral research elucidating central mechanisms of sexual desire Extensive publication record on bremelanotide efficacy, safety, and clinical applications Her work has established PT-141 as the second FDA-approved pharmacological treatment for HSDD and the first melanocortin-based therapy for sexual dysfunction, representing a significant advance in womens sexual health treatment options
US$ 28.64
US$ 26.00
US$ 21.57
US$ 26.98
US$ 25.72
US$ 27.96
US$ 28.35
US$ 29.24
US$ 27.41
US$ 23.72
